Received: 26 January 2022
Revised: 18 February 2022
Accepted: 18 February 2022
First Online: 9 March 2022
: Andres Acosta is a stockholder in Gila Therapeutics, Phenomix Sciences; he served as a consultant for Rhythm Pharmaceuticals, General Mills. Lizeth Cifuentes, Maria D. Hurtado, Tiffany M. Cortes, Kristen Gonzales, Meera Shah, and Maria L. Collazo-Clavell declare that they have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal informed consent is not required and does not apply.